Transitory beneficial effects of professional continuous glucose monitoring on the metabolic control of patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 4, 2014, Pages 219-223

  Patrascioiu, Ioana ^a   Quirós, Carmen ^a   Ríos, Paola ^a   Ruíz, Montserrat ^a   Mayordomo, Rosa ^a   Conget, Ignacio ^a   Giménez, Marga ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CONTINUOUS INFUSION; DECISION SUPPORT SYSTEM; DIABETIC DIET; DIABETIC PATIENT; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC REGULATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADULT; BLOOD; DIABETES MELLITUS, TYPE 1; FOLLOW UP; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; PHYSIOLOGIC MONITORING; QUALITY OF LIFE; TIME;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MONITORING, PHYSIOLOGIC; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84896350348     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0266     Document Type: Article

References (12)

1. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dai-ley G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
3. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J; SWITCH Study Group: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia 2012; 55:3155-3162.
4. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232.
5. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030-2034. (Pubitemid 33716516)
6. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell PJ, Temple RC: Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ 2008;337:a1680.
7. Chico A, Vidal-Ŕios P, Subirà M, Novials A: The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157. (Pubitemid 36929264)
8. Sciaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crinò A: The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 2002; 18:324-329.
9. Langendam M, Luijf YM, Hooft L, DeVries JH, Mudde AH, Scholten RJ: Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012; 1:CD008101.
10. Pepper GM, Steinsapir J, Reynolds K: Effect of short-term iPro continuous glucose monitoring on hemoglobin A1c levels in clinical practice. Diabetes Technol Ther 2012;14:654-657.
11. Leinung M, Nardacci E, Patel N, Bettadahalli S, Paika K, Thompson S: Benefits of short-term professional continuous glucose monitoring in clinical practice. Diabetes Technol Ther 2013;15:744-747.
12. American Diabetes Association: Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1):S11-S66.